Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE

K-Number: K870807 · 1987-05-29

ApplicantAllergan, Inc.
Decision Date1987-05-29
Product CodeHNO
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE is the device name listed in this FDA 510(k) record. The listed applicant is Allergan, Inc.. It received FDA 510(k) clearance on 1987-05-29 under 510(k) number K870807. The device is classified under product code HNO. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE?

BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE is a medical device that received FDA 510(k) clearance on 1987-05-29. The listed applicant is Allergan, Inc.. The 510(k) number is K870807.

When did BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE receive FDA 510(k) clearance?

BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE received FDA 510(k) clearance on 1987-05-29, under 510(k) number K870807.

Who is the listed applicant for BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE?

The FDA 510(k) record lists Allergan, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE?

The FDA product code for BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE is HNO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Allergan, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K190674REFRESH RELIEVA For CONTACTSK161457XEN Glaucoma Treatment SystemK083812REFRESH OPTIVE LENS COMFORT REWETTING DROPSK051852SINGLE AMPLIFIER FOR BOTOXK014202COMPLETE BRAND MULTI-PURPOSE SOLUTIONK013479COMPLETE BRAND MULTI-PURPOSE SOLUTION

View all 32 devices →

Related Devices (Code: HNO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K173371VisuMax Femtosecond LaserCarl Zeiss Meditec, Inc.K172994EPI K ConsoleMoria SAK072102EPIVISION SL SYSTEMGebauer Medizintechnik GmbHK082043CARRIAZO-PENDULAR MICROKERATOMESchwind Eye-Tech-Solutions GmbH & Co. KGK062465ZYOPTIX XP EPI SEPARATOR SYSTEMBausch & Lomb, Inc.K052891HORIZON EPIKERATOME DISPOSABLE MICROKERATOME SYSTEMHawken Industries

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑